¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cell cloning"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • non-small cell carcinoma
    ºñ¼Ò¼¼Æ÷¾ÏÁ¾
  • nucleated cell
    À¯ÇÙ¼¼Æ÷
  • null cell
    ¹«Ç¥Áö¼¼Æ÷
  • nurse cell
    ¿µ¾ç¼¼Æ÷
  • natural killer cell
    ÀÚ¿¬»ìÇØ¼¼Æ÷
  • oat cell carcinoma
    ±Í¸®¼¼Æ÷¾ÏÁ¾
  • osmiophilic cell
    ¿À½º¹Åģȭ¼¼Æ÷
  • oxyntic cell
    º®¼¼Æ÷
  • oxyphilic cell
    È£»ê¼¼Æ÷
  • pheochrome cell
    Å©·Òģȭ¼¼Æ÷
  • photoreceptor cell
    ±¤¼ö¿ë±â¼¼Æ÷
  • physaliphorous cell
    °Åǰ¼¼Æ÷
  • Pick cell
    Çȼ¼Æ÷
  • pigment cell
    »ö¼Ò¼¼Æ÷
  • pigment cell nevus
    »ö¼Ò¼¼Æ÷¸ð¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • slide cell culture
    ½½¶óÀ̵弼Æ÷¹è¾ç
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
  • small cell lung cancer
    ÀÛÀº¼¼Æ÷ÇãÆÄ¾Ï, ¼Ò¼¼Æ÷Æó¾Ï
  • sperm cell
    (¢¡spermatozoon) Á¤ÀÚ
  • spermatogenic cell
    Á¤Àڹ߻ý¼¼Æ÷
  • spherical cell
    µÕ±Ù¼¼Æ÷
  • spindle cell
    ¹æÃß¼¼Æ÷
  • spindle cell carcinoma
    ¹æÃß¼¼Æ÷¾ÏÁ¾
  • spur cell
    µ¹±â¼¼Æ÷, °¡½ÃÀûÇ÷±¸
  • squamous cell
    ÆíÆò¼¼Æ÷
  • squamous cell carcinoma
    ÆíÆò¼¼Æ÷¾ÏÁ¾
  • stable cell
    ¾ÈÁ¤¼¼Æ÷
  • stellate cell
    º°¼¼Æ÷
  • stem cell
    Áٱ⼼Æ÷, Á¶Ç÷¸ð¼¼Æ÷
  • stichosome cell
    ¿°ÁÖ¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • interaction, T-T cell
    T¼¼Æ÷°£ »óÈ£ÀÛ¿ë
  • persensitized cell
    °ú°¨ÀÛ¼¼Æ÷(ΦÊïíÂá¬øà)
  • petrous tip cell
    Ãßü÷ºÀ¼Ò.
  • photochemical cell
    ±¤È­ÇÐÀüÁö(ÎÃûùùÊ ï³ò®).
  • photoconductive cell
    ±¤Àüµµ¼ÒÀÚ(¡­áÈí­).
  • photoelectric cell
    ±¤ÀüÁö(ÎÃï³ò®).
  • physaliphorous cell
    ´ã°øÆ÷¼¼Æ÷(Ó½Íöøàá¬øà)
  • pigment cell
    »ö¼Ò¼¼Æ÷(ßäáÈá¬øà).
  • pigment cell
    »ö¼Ò¼¼Æ÷
  • pigment cell nevus
    »ö¼Ò¼¼Æ÷¸ð¹Ý
  • pigment cell nevus
    »ö¼Ò¼¼Æ÷¸ð¹Ý(ßäáÈá¬øàÙ½Úè)
  • pigment epithelial cell
    »ö¼Ò»óÇǼ¼Æ÷
  • pigmented basal cell carcinoma
    »ö¼ÒÄ§Âø ±âÀú¼¼Æ÷¾Ï
  • pillar cell
    ÁÖ¼¼Æ÷(ñºá¬øà).
  • pilomotor cell
    ¸ð¹ß¿îµ¿¼¼Æ÷(¡­ê¡ÔÑá¬øà).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • cell,hydropic degeneration
    ¼öÆ÷¼º º¯¼º(â©øÜàõܨà÷)
  • cell,hyperplasia
    °úÇü¼º(Φû¡à÷), Áõ½Ä(ñòãÖ)
  • cell,hypertrophy
    ºñÈÄ(Ýþý§)
  • cell,ischemic and hypoxic in jury
    ±¹¼ÒºóÇ÷¼º(ÏÑá¶Þ¸úìàõ), Àú»ê¼Ò¼º ¼Õ»ó(î¸ß«áÈàõáßß¿)
  • cell,labile
    ºÒ¾ÈÁ¤(ÝÕäÌïÒ)
  • cell,metaplasia
    È­»ý(ûùßæ)
  • cell,necrotic
    ±«»ç¼º(ÎÕÞÝàõ)
  • cell,proliferation
    Áõ½Ä(ñòãÖ)
  • cell,radiosensitivity
    ¹æ»ç¼º °¨¼ö¼º(Û¯ÞÒàõÊïáôàõ)
  • cell,smooth muscle
    ÆòȰ±Ù (øÁüÁÐÉ)
  • cell,stable
    ¾ÈÁ¤(äÌïÒ)
  • cell,swelling
    Á¾Ã¢(ðþóì)
  • cell-associated antibody
    ¼¼Æ÷°áÇÕÇ×ü(á¬øàÌ¿ùêù÷ô÷), ¼¼Æ÷°íÁ¤Ç×ü, ¼¼Æ÷°ü ·ÃÇ×ü.
  • cell-associated virus
    ¼¼Æ÷ºÎÂø¹ÙÀÌ·¯½º
  • cell-bound antibody
    [³»°ú]¼¼Æ÷°áÇÕÇ×ü(á¬øàÌ¿ùêù÷ô÷).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
ABCIL antibody-mediated cell-dependent immunolympholysis
ABPC antibody-producing cell
AC abdominal circumference; abdominal compression; absorption coefficient; abuse case; acetate; acetylc...
ACAC acetyl-coenzyme A cocarboxylase; activated charcoal artificial cell
ACCESS Ambulatory Care Clinic Effectiveness Systems Study; automated cervical cell screening system
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
CBV Capillary blood cell velocity
14C Cell
CAM Cell Adhesion Molecule
CML Cell Mediated Lympholysis
CTA Cell Transit Analyser
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • residential cell
    Á¤ÁÖ ¼¼Æ÷
  • reticulum cell
    ¼¼¸Á ¼¼Æ÷
  • retinal cell
    ¸Á¸· ¼¼Æ÷
  • rheumatoid arthritis cell
    ·ù¸¶ÅäÀÌµå °üÀý¿° ¼¼Æ÷
  • Rieder's cell
    ¸®ÀÌ´õ ¼¼Æ÷
    ¾î¶² Á¾·ùÀÇ °ñ¼º ¹éÇ÷º´ Áß¿¡¼­ ³ªÅ¸³ª´Â ºÐÈ­µÇÁö ¾ÊÀº °ñºÎ¾Æ±¸·Î¼­, ¿øÇüÁúÀº û»öÀ¸·Î ÁøÇÏ°Ô ¿°»öµÇ°í, ÇÙÀº ½ÉÇÑ ÇԿ並 ³ªÅ¸³»¸ç, ¸¶Ä¡ ºÐ¿± ÇÙ°ú ºñ½ÁÇÑ ÇüŸ¦ ³ªÅ¸³»´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • rod cell
    °£»ó ¼¼Æ÷
    ´«ÀÇ ¸Á¸·¿¡¼­ ºûÀ» °¨ÁöÇÏ´Â ¼¼Æ÷. ºÀ»ó ¼¼Æ÷, °£»óü, °£Ã¼¶ó°íµµ ÇÑ´Ù. ¸·´ë ¸ð¾çÀ» Çϰí ÀÖ¾î, ¿µ¾î·Î ·Îµå
  • RVM off-cell
    Àüº¹Ãø ¿¬¼ö Áß´Ü ¼¼Æ÷
  • S : SulfurÀÇ ¾àÀÚ.

    S cell

    S ¼¼Æ÷
    ½Ã½ºÅ×ÀÎ
  • Sala's cell
    »ì¶ó ¼¼Æ÷
    ½É¸· ³»¿¡ À§Ä¡ÇÏ´Â °¨°¢ ½Å°æ ¸»´ÜÀ» Çü¼ºÇÏ´Â ¼¶À¯ ³» °áÇÕ Á¶Á÷ÀÇ ¼º»ó ¼¼Æ÷.
  • Schwann cell cytoplasm
    Schwann ¼¼Æ÷Áú
  • Schwann's cell
    ½´¹Ý ¼¼Æ÷
    ¼öÃÊÀý¿¡ Çϳª¾¿ ¹èÄ¡µÇ¸ç, ¶÷ºñ¿¡ ±³·û¿¡¼­ ³¡³­´Ù. ¸»ÃÊ¿¡¼­ ¼öÃʳª ½´¹ÝÃʸ¦ Çü¼ºÇÑ´Ù.
  • second-order cell
    ÀÌÂ÷ ¼¼Æ÷
  • secretory cell
    ºÐºñ ¼¼Æ÷
  • seminoma cell
    Á¤»ó ÇÇÁ¾ ¼¼Æ÷
    °íȯÀÇ ÀüÇüÀû Á¤»óÇÇÁ¾¿¡¼­ ³ªÅ¸³ª´Â Ä¿´Ù¶õ µÕ±Ù ¼¼Æ÷·Î¼­ dzºÎÇÑ ¼¼Æ÷ÁúÀÇ Áß¾Ó¿¡ 1°³ ȤÀº ±× ÀÌ»óÀÇ ÇÙ¼Òü¸¦ °¡Áø ºñ±³Àû Å« ÇÙÀ» °®°í ÀÖ´Ù.
  • sensitized cell
    °¨ÀÛ Ç÷±¸
    ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü¿Í ÀûÇ÷±¸¸¦ °áÇÕ½ÃŲ °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
cell locomotion <cell biology> Movement of a cell from one place to another.
(26 Mar 1998)
cell marker <cell biology> Biochemical or genetic characteristics which distinguish and discriminate between different cell types.
(26 Mar 1998)
cell matrix A fluid cytoplasmic substance filling the interstices of the cytoskeleton.
Synonym: cell matrix, cytomatrix.
(05 Mar 2000)
cell-mediated immunity <immunology> Immune response that involves effector T lymphocytes and not the production of humoral antibody.
Responsible for allograft rejection, delayed hypersensitivity and in defence against viral infection and intracellular protozoan parasites.
(26 Mar 1998)
cell-mediated reaction Immunological reaction of the delayed type, involving chiefly T lymphocytes, important in host defense against infection, in autoimmune diseases, and in transplant rejection.
See: skin test.
(05 Mar 2000)
cell membrane <cell biology> The structure enveloping a cell, enclosing the cytoplasm and forming a selective permeability barrier.
It consists of lipids, proteins and some carbohydrates, the lipids thought to form a bilayer in which integral proteins are embedded to varying degrees.
Synonym: plasma membrane.
(26 Mar 1998)
cell membrane permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells.
(12 Dec 1998)
cell migration <cell biology> Implies movement of a population of cells from one place to another as in the movement of neural crest cells during morphogenesis.
(26 Mar 1998)
cell migration inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated leukocytes or macrophages. Specific assays have been developed to estimate levels of migration-inhibitory factor, immune reactivity against tumour-associated antigens, and immunosuppressive effects of infectious microorganisms.
(12 Dec 1998)
cell movement <cell biology> A more general term than locomotion, that can include shape change, cytoplasmic streaming etc.
(26 Mar 1998)
cell nucleolus Within most types of eukaryotic cell nucleus, a distinct region, not delimited by a membrane, in which some species of rrna (RNA, ribosomal) are synthesised and assembled into ribonucleoprotein subunits of ribosomes. In the nucleolus rrna is transcribed from a nucleolar organiser, i.e., a group of tandemly repeated chromosomal genes which encode rrna and which are transcribed by RNA polymerase I.
(12 Dec 1998)
cell nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (cell nucleolus). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the endoplasmic reticulum. A cell may contain more than one nucleus.
(12 Dec 1998)
P cell A characteristic specialised cell, with probable pacemaker function, found in the S-A node and A-V junction.
(05 Mar 2000)
cell organelle <cell biology> A structurally discrete component of a cell.
(18 Nov 1997)
cell physiology Characteristics and physiological processes of cells from cell division to cell death.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á